EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment

Szymon Zmorzynski, Aleksandra Kimicka-Szajwaj, Angelika Szajwaj, Joanna Czerwik-Marcinkowska iD, Jacek Wojcierowski

Genes · 2024

DOI: 10.3390/genes15010137 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2024. Verfasst von Szymon Zmorzynski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genetics, Academy of Zamosc, 22-400 Zamosc, Poland. Hauptthemen laut MEDLINE: Mastocytosis, Myeloproliferative Disorders, MicroRNAs. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 302 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mast cell tumors are a large group of diseases occurring in dogs, cats, mice, as well as in humans. Systemic mastocytosis (SM) is a disease involving the accumulation of mast cells in organs. KIT gene mutations are very often seen in abnormal mast cells. In SM, high KIT/CD117 expression is observed; however, there are usually no KIT gene mutations present. Mastocytoma (MCT)—a form of cutaneous neoplasm—is common in animals but quite rare in humans. KIT/CD117 receptor mutations were studied as the typical changes for human mastocytosis. In 80% of human cases, the KIT gene substitution p.D816H was present. In about 25% of MCTs, metastasis was observed. Changes in the gene expression of certain genes, such as overexpression of the DNAJ3A3 gene, promote metastasis. In contrast, the SNORD93 gene blocks the expression of metastasis genes. The panel of miR-21-5p, miR-379, and miR-885 has a good efficiency in discriminating healthy and MCT-affected dogs, as well as MCT-affected dogs with and without nodal metastasis. Further studies on the pathobiology of mast cells can lead to clinical improvements, such as better MCT diagnosis and treatment. Our paper reviews studies on the topic of mast cells, which have been carried out over the past few years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MastocytosisMyeloproliferative DisordersMicroRNAsHumansAnimalsDogsMiceMast CellsProto-Oncogene Proteins c-kitPrognosis

Stichwörter der Autor:innen

genesmast cellsmastocytesmastocytomamastocytosismicroRNAmutations

Substanzen

Proto-Oncogene Proteins c-kitMicroRNAs

Autor:innen und Institutionen

  • Laboratory of Genetics, Academy of Zamosc, 22-400 Zamosc, Poland.
  • DVM Veterinary Hospital AMVET, 31-328 Krakow, Poland.
  • St. Luke's Hospital in Tarnow, 33-100 Tarnow, Poland.
  • Institute of Biology, Jan Kochanowski University, 25-369 Kielce, Poland.
  • Laboratory for Genetic Testing, 20-143 Lublin, Poland.

ORCID-Profile: Joanna Czerwik-Marcinkowska

Zitieren

APA

Zmorzynski, S., Kimicka-Szajwaj, A., Szajwaj, A., Czerwik-Marcinkowska, J., & Wojcierowski, J. (2024). Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment. Genes. https://doi.org/10.3390/genes15010137

Vancouver

Zmorzynski S, Kimicka-Szajwaj A, Szajwaj A, Czerwik-Marcinkowska J, Wojcierowski J. Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment. Genes. 2024. doi:10.3390/genes15010137

BibTeX
@article{Zmorzynski2024,
  author = {Zmorzynski, Szymon and Kimicka-Szajwaj, Aleksandra and Szajwaj, Angelika and Czerwik-Marcinkowska, Joanna and Wojcierowski, Jacek},
  title = {Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15010137}
}
Kostenlos starten →